Staging Alzheimer's Disease Using Blood Samples
Principal Investigator
Mentors
-
Oskar Hansson, MD, PhD
Project Goals
To use accurate novel blood-based biomarkers and proteomics for a better and more accessible diagnosis and prognosis of Alzheimer’s disease, for a more personalized healthcare.
Project Summary
Researchers will develop a staging model for Alzheimer’s disease based on plasma biomarkers, which will help characterize people across the different phases of the disease. The study will also investigate how multiple protein levels change across these stages to better understand the complex biological processes that occur during the disease. Researchers envision that the staging model may help decide, in an easy and cost-effective way, who would benefit from a treatment against Alzheimer's disease and perform a more personalized management of the individual. Studying protein changes may also unveil new drug targets for Alzheimer’s.
Publications
First published on: July 29, 2024
Last modified on: September 10, 2024